RBM5 and metastatic malignant neoplasm in the lymph nodes: Additionally, underexpression of RBM5 had a close association with unfavorable clinicopathological features, including lymph node metastasis, distant metastasis, advanced UICC stage and presence of nerve and venous invasion, suggesting its potential role in tumor invasion and progression.